Control glucmico (DM2): Diferentes ensayos SUSTAIN y otros muestran descensos de hemoglobina glicosilada (HbA1c) de aproximadamente 1%1,5% con semaglutida subcutnea 0,51 mg/semana
This typically occurs 3 to 6 months after significant weight loss begins and resolves on its own within 6 to 12 months
Information provided does not replace professional healthcare judgment
You typically cannot control these variables, as they are determined by the pharmacy during formulation
About the SELECT trial and SCORE real-world study: SELECT was a randomised, double-blind, parallel-group, placebo-controlled trial designed to evaluate the efficacy of Wegovy (semaglutide 2.4 mg) versus placebo as an adjunct to standard of care for the prevention of MACE in people with overweight or obesity and established CVD with no prior history of diabetes
The concern is purely about the timing relative to sublingual absorption